Pharmaceutical Technology4 小时
Ibudilast by MediciNova for Chemotherapy Induced Peripheral Neuropathy: Likelihood of Approval
Ibudilast is under clinical development by MediciNova and currently in Phase II for Chemotherapy Induced Peripheral Neuropathy.
Pharmaceutical Technology5 小时
Capsaicin by Grunenthal for Chemotherapy Induced Peripheral Neuropathy: Likelihood of Approval
Capsaicin is under clinical development by Grunenthal and currently in Phase III for Chemotherapy Induced Peripheral Neuropathy.